Effect of nagaradi modak in the management of vataj kasa (acute bronchitis)

Randomized controlled clinical trial to evaluate the efficacy of nagaradi modak in the management of vataj kasa (acute bronchitis) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103410

Enrollment

Registered

2026-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of Age group 18 to 45 yrs. 2. Patients irrespective of Gender, Religion Profession, Marital status and Socioeconomic status. 3. Patients showing Classical Lakshanas of Vataj Kasa that mentioned in Samhita.

Exclusion criteria

Exclusion criteria: 1. Patient with other severe systemic disorder and also sign and symptoms other than Vataj Kasa. 2. Patient with known respiratory disorder like Tuberculosis, COPD, Asthma, CA lungs any any other known respiratory disease. 3. Pregnant and lactating mothers. 4. Patient below age group 18 years & above 60 years will be excluded

Design outcomes

Primary

Measure	Time frame
1. Shushka Kasa (Dry Cough) 2. Shirashoola (Headache) 3. Uraha shoola (Chest pain) will be reducedTimepoint: 14 days	—

Secondary

Measure	Time frame
1. Daurabalya (General Weakness) 2. Parshwashoola (Pain in thoracic region) will be reduced Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Ashutosh Prabhakar Shinde

C.S.M.S.S Ayurved Mahavidhyalaya and Rugnalaya

dr.shrikantgdeshmukh@gmail.com9921553999

Outcome results